Dhanwantaram Gutika in classical Ayurveda

What it is

A gutika is a pill: powdered herbs (and sometimes minerals) bound and rolled into tablets, the most portable classical dosage form. Dhanwantaram Gutika belongs to the Dhanwantaram family of formulations named for Dhanwantari, the Ayurvedic deity-physician, a family that also includes the well-known Dhanwantaram Tailam and Kashayam. The 2025 standardization study describes it as an Ayurvedic formulation in Sahasrayoga useful in gastritis, cough, and vomiting (Sukumaran et al., J Med Plants Stud 13(2), 2025).

Note the spelling variants: Dhanwantaram / Dhanvantari / Dhanwantharam Gutika all refer to the same classical tablet. This article uses the batch slug's spelling.

Classical properties

• Taste (rasa): pungent (Katu), bitter (Tikta)
• Qualities (guna): light (Laghu)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata and Kapha; may increase Pitta

Traditional use

Per the standardization paper's summary of the classical literature, Dhanwantaram Gutika is used for gastritis-type complaints, cough, and vomiting (Sukumaran et al., 2025). The 1998 pharmacology paper adds that it is "prescribed in different diseases including rheumatism" (Alam et al., Ancient Science of Life 1998). These are traditional attributions; only the anti-inflammatory one has any experimental test, described below.

What research has looked at

Animal experiment: cotton-pellet granuloma in rats (1998)

Alam et al., at the Captain Srinivasa Murti Drug Research Institute for Ayurveda (Madras), screened Dhanvantara Gutika alongside Balarishta. They tested anti-inflammatory activity against cotton-pellet-induced granuloma in albino rats, with phenylbutazone as the reference drug. The gutika significantly reduced granuloma (cotton-pellet) weight, significantly reduced adrenal ascorbic acid, and significantly reduced acid phosphatase, GPT, and GOT activities in liver. Serum acid phosphatase and GOT were also reduced. The authors interpreted the enzyme pattern as lysosomal membrane stabilization and concluded both tested drugs "possess anti-inflammatory activity" (Alam et al., 1998).

This is a genuine anti-inflammatory signal in a chronic-inflammation rat model, from a government Ayurveda drug research institute. Its limits: a single animal model, no dose-response details recoverable from the abstract, no human data, and no test of the gutika's traditional indications (gastritis, cough, vomiting).

Pharmaceutical standardization (2025)

Sukumaran et al. standardized Dhanvantari Gutika across five parameter groups. Organoleptic: colour, odour, taste, shape. Physicochemical: ash values, extractive values, pH, loss on drying, foaming index. Phytochemical: screening, TLC, HPTLC. Pharmaceutical: hardness, friability, weight variation, disintegration time. Toxicological: sterility, heavy metals by atomic absorption spectroscopy. They found all parameters within the norms specified by the Ayurvedic Pharmacopoeia of India for tablets (J Med Plants Stud 13(2), 2025).

This is quality science, not efficacy science: it shows a well-made tablet meets pharmacopoeial standards, not that the tablet works.

What the evidence does not support (yet)

• No human trials. Neither the anti-inflammatory effect nor any traditional indication has been tested in people.
• No mechanism studies. The lysosomal-stabilization interpretation is the authors' inference from enzyme patterns, not a demonstrated mechanism.
• No safety pharmacology beyond the tablet QC. The 2025 study's sterility and heavy-metal checks are manufacturing quality tests, not clinical safety data.

Safety notes

No human safety data exist. Cautions:

• Formulas vary by manufacturer. "Dhanwantaram Gutika" from different makers may differ in composition; the 1998 and 2025 studies each tested their own samples.
• Gastritis needs proper assessment. Persistent gastritis-type pain, vomiting, or cough warrant medical evaluation. A traditional tablet is not a substitute for diagnosis.
• No data on pregnancy, breastfeeding, children, or drug interactions. Use under practitioner supervision.

FAQs

What is Dhanwantaram Gutika?

A classical Ayurvedic tablet described in Sahasrayoga, traditionally used for gastritis, cough, and vomiting, a member of the Dhanwantaram formulation family.

Does it reduce inflammation?

In one 1998 rat study of granuloma-type inflammation, it significantly reduced inflammatory tissue weight and inflammatory enzyme markers. No human study has tested this.

Is it the same as Dhanwantaram Tailam or Kashayam?

No. Same family name, different dosage forms. The tailam is a medicated oil and the kashayam a decoction; the gutika is a tablet. Evidence for one does not transfer to the others.

What is the recommended dose?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Annotated Sources

The Sahasrayoga identity, traditional indications (gastritis, cough, vomiting), and the full standardization panel (organoleptic, physicochemical, phytochemical, pharmaceutical, and toxicological parameters within Ayurvedic Pharmacopoeia of India norms) are from Sukumaran et al., Journal of Medicinal Plants Studies 13(2):158–163, 2025 (PDF). The rat cotton-pellet granuloma experiment (significant granuloma-weight reduction; adrenal ascorbic acid, liver acid phosphatase/GPT/GOT, and serum enzyme reductions; phenylbutazone reference) is Alam et al., Ancient Science of Life 1998 (PMC full text).

Disclaimer

This article is for educational purposes only and is not medical advice. Dhanwantaram Gutika has no human trials and no clinical safety data; the available evidence is one rat inflammation experiment and one manufacturing-quality study. Persistent gastritis, vomiting, or cough need proper medical assessment. Use only products from reputable manufacturers and only under the supervision of a qualified practitioner — especially if pregnant, breastfeeding, managing a medical condition, giving it to a child, or taking prescription medicines.